Cambridge Heart, Inc. Reports Preliminary Results for the Three and Six Months Ended June 30, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported preliminary revenue results for the three and six months ended June 30, 2012. Revenue for the second quarter is expected to total $450,000 compared to $542,000 in the prior year, and revenue for the six-month period is expected to total $1,004,000 compared to $1,179,000 in the same six-month period in 2011.